#Farapulse
LightNews LightNews
rcnworldwidemedia.bsky.social
CAYMAN ISLANDS: Health City Performs Caribbean’s First FARAPULSE™ Procedure for Atrial Fibrillation
rcnworldwidemedia.blogspot.com/2026/07/caym...
CAYMAN ISLANDS: Health City Performs Caribbean’s First FARAPULSE™ Procedure for Atrial Fibrillation
rcnworldwidemedia.blogspot.com
July 31, 2026 at 5:39 PM
research.migraine.kr
The incidence of new-onset migraine was comparable between different systems; 1.69% (95% CI 1.10%-2.49%), 1.65% (95% CI 0.54%-3.82%), and 0.27% (95% CI 0.01%-1.50%) for Farapulse, Sphere 9, and Pulse Select, respectively. (🧵 7/9)
June 16, 2026 at 8:32 AM
research.migraine.kr
New-onset migraine was diagnosed in 31 (1.4%) post-PFA patients. Of these 31 patients, 25 (80.6%) underwent PFA using the Farapulse system, Sphere 9 in 5 (16.12%), and Pulse Select in 1 (3.22%) patient. (🧵 6/9)
June 16, 2026 at 8:32 AM
paper.migraine.kr
신규 편두통의 발생률은 각 시스템 간에 유사한 수준이었으며, Farapulse의 경우 1.69%(95% CI 1.10%-2.49%), Farapulse, Sphere 9, Pulse Select의 경우 각각 1.69%(95% CI 0.54%-3.82%), 1.65%(95% CI 0.54%-3.82%), 0.27%(95% CI 0.01%-1.50%)였다. (🧵 4/6)
June 16, 2026 at 8:29 AM
paper.migraine.kr
편두통 병력이 있는 환자는 32명(1.48%)이었으며, 이 중 6명(18.75%)은 절제술 직후 편두통 빈도가 증가했다고 보고했다. PFA 시술 후 31명(1.4%)에서 신규 편두통이 진단되었다. 이 31명의 환자 중 25명(80.6%)은 Farapulse 시스템을 사용하여 PFA를 받았고, 5명(16.12%)은 Sphere 9를, 1명(3.22%)은 Pulse Select를 사용하여 PFA를 받았습니다. (🧵 3/6)
June 16, 2026 at 8:29 AM
bsccardiology.bsky.social
Registration is open for TransformAF 2026, September 24–26 in Orlando, Florida.

Two immersive days. Real cases. Hands-on learning.

Reserve your spot and learn how the FARAPULSE ™ PFA Platform is building new possibilities for the future of EP: qrco.de/bgp94c
TransformAF 2026 | Sepember 24-26 | Orlando, FL
May 27, 2026 at 1:00 PM
bsccardiology.bsky.social
FARAPULSE Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX
OPAL HDx Mapping System Indications, Safety, and Warnings: qrco.de/bfsrBM
May 26, 2026 at 6:32 PM
bsccardiology.bsky.social
See FARAWATCH™ in action! Dr. Ilana Kutinksy recently performed her first concomitant case with the FARAPULSE™ PFA Platform and WATCHMAN FLX™ Pro LAAC Device, utilizing the OPAL HDx™ Mapping System, the WATCHMAN TruSteer™ Access System, and a 4D ICE catheter.

Learn more: qrco.de/bgpj0F
May 26, 2026 at 6:29 PM
fancool0.bsky.social
@olbermann.bsky.social go straight for the pulse field ablation.

www.farapulse.com/us/en/hcp/cl...
Clinical Evidence - FARAPULSE™ Pulsed Field Ablation (PFA) System
FARAPULSE PFA is the most studied pulsed field ablation technology, with unmatched data from pivotal trials and real-world registries.
www.farapulse.com
May 13, 2026 at 4:20 PM
blueresearch.bsky.social
Boston Scientific announces data on Farapulse PFA Platform, Watchman LAAC
Reported Sunday, Apr 26 - 1:41pm EDT (TheFly subscription required to read more.)
thefly.com
April 26, 2026 at 5:50 PM
newsen.bsky.social
Boston Scientific Unveils Innovative Therapies at Heart Rhythm 2026 Conference#USA#Chicago#Boston_Scientific#FARAPULSE#WATCHMAN
Boston Scientific Unveils Innovative Therapies at Heart Rhythm 2026 Conference
Boston Scientific highlighted their latest therapies at Heart Rhythm 2026, showcasing the FARAPULSE PFA Platform and WATCHMAN LAAC technologies with promising clinical trial data.
third-news.com
April 26, 2026 at 5:07 PM
l2plabs.bsky.social
Data at Heart Rhythm 2026 highlight key Boston Scientific therapies
Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions MARLBOROUGH, Mass. and CHICAGO, April 26, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data...
dlvr.it
April 26, 2026 at 5:04 PM
longtail-news.bsky.social
Feed: "News Releases - Boston Scientific"
Published on Sunday, April 26, 2026
Data at Heart Rhythm 2026 highlight key Boston Scientific therapies
Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions MARLBOROUGH, Mass. and...
news.bostonscientific.com
April 26, 2026 at 5:02 PM
stocktitan.net
#BSX Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

https://www.stocktitan.net/news/BSX/data-at-heart-rhythm-2026-highlight-key-boston-scientific-i8slgxadgwi4.html
Data at Heart Rhythm 2026 highlight key Boston Scientific therapies
Boston Scientific (NYSE: BSX) presented multiple late-breaking clinical results at Heart Rhythm 2026 highlighting FARAPULSE PFA and WATCHMAN LAAC technologies. Key outcomes: AVANT GUARD showed PFA superiority over anti-arrhythmic drugs (56.0% vs 30.1% primary effectiveness at 12 months); PFA safety MAE 5.1%. Feasibility and real-world cohorts reported high PVI durability (up to 96.4%) and procedural success for combined PFA+WATCHMAN procedures.Long-term and subgroup data showed WATCHMAN reduced non-procedural bleeding versus NOACs and lower stroke rates versus control in ASAP-TOO, though some studies had enrollment or sample-size limits.
www.stocktitan.net
April 26, 2026 at 5:00 PM
bsccardiology.bsky.social
Review the results
qrco.de/bglXCd

#Epeeps #PulsedFieldAblation
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings:
qrco.de/bfsrJX
April 25, 2026 at 5:05 PM
bsccardiology.bsky.social
PRIMARY ENDPOINTS MET. New AVANT GUARD data presented at #HRS2026 evaluated the safety and effectiveness of FARAPULSE™ PFA* vs antiarrhythmic drug (AAD) therapy as a first line treatment for persistent atrial fibrillation.

*Delivered with the FARAWAVE™ Pulsed Field Ablation (PFA) Catheter
April 25, 2026 at 5:04 PM
ad-hoc-news.de.web.brid.gy
Boston Scientific Aktie: Radikaler Schnitt!
Boston Scientific meldet klinische Bestwerte für sein Farapulse-System, doch die Aktie notiert nahe dem Jahrestief. Die Quartalszahlen Ende April sind entscheidend für eine Trendwende.
www.ad-hoc-news.de
April 15, 2026 at 1:41 AM
bsccardiology.bsky.social
📊Catch the latest FARAPULSE™ PFA Platform data at #HRS2026. Don’t miss AVANT GUARD primary outcomes, the ELEVATE-PF feasibility study, in-booth roundtables and more.
View the full program:
qrco.de/bgikIt

FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX
FARAPULSE™ PFA Platform data at #HRS2026
April 7, 2026 at 1:00 PM
bsccardiology.bsky.social
Learn more about FARAPOINT:
qrco.de/bgiK3j

FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX

OPAL™ HDx Mapping System Indications, Safety, and Warnings: qrco.de/bfsrBM
March 31, 2026 at 2:37 PM
bsccardiology.bsky.social
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX
February 7, 2026 at 2:28 PM
bsccardiology.bsky.social
Long-term #PFA data matters. FARAPULSE™ PFA delivered.

ADVENT LTO was the first clinical study to report outcomes out to 4 years from a randomized cohort of patients comparing PFA vs. thermal ablation, showing FARAPULSE™ PFA outperformed thermal. See the full study: qrco.de/bgbmX9
February 7, 2026 at 2:28 PM
bsccardiology.bsky.social
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX
February 5, 2026 at 5:15 PM
bsccardiology.bsky.social
📊Catch these Late-Breaking Clinical Science Sessions and other key FARAPULSE™ PFA Platform data releases at #AFSymposium2026 this weekend!

View the full program here: qrco.de/bgatmg

AF Symposium 2026, Late-breaking FARAPULSE PFA Platform Clinical Data
February 4, 2026 at 2:00 PM
bsccardiology.bsky.social
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX

OPAL HDx™ Mapping System Indications, Safety, and Warnings: qrco.de/bfsrBM
January 15, 2026 at 6:46 PM